Outcome and Prognosis
Regardless of the etiology of gynecomastia, the prognosis is excellent when surgery is performed by a surgeon experienced with the disorder. In pathological-induced gynecomastia, medical and surgical treatment of the cause is required. In drug-induced gynecomastia, withdrawal of the medication leads to regression in 60% of patients. If the gynecomastia is of long duration, it is unlikely to spontaneously regress.
Future and Controversies
Drug-induced gynecomastia and gynecomastia due to long-term exposure to estrogen are believed by some to increase a patient's risk for breast cancer. However, numerous clinical studies have failed to show the relationship between breast cancer and gynecomastia. The only study which shows clear association between gynecomastia and male breast cancer is with Klinefelter syndrome; patients who have gynecomastia and Klinefelter syndrome are at about 50% increased risk of male breast cancer. Drug-induced gynecomastia is the second most common cause of gynecomastia. Significant studies have been conducted to research the effects of the drugs that cause gynecomastia; however, much additional work is required.
If the gynecomastia patient is not satisfied with an otherwise excellent surgical result or a clear history of abuse from having the condition is noted, therapy may be required, and the appropriate referral should be recommended. Resolving any severe overlying emotional issues produces a much higher satisfaction rate with the surgical outcome in these individuals.
In general, the management of gynecomastia is not controversial; its typically benign nature and the indications for medical and surgical management are well established.
More on Gynecomastia |
| Overview: Gynecomastia |
| Workup: Gynecomastia |
| Treatment: Gynecomastia |
Follow-up: Gynecomastia |
| Multimedia: Gynecomastia |
| References |
| « Previous Page | Next Page » |
References
Devalia HL, Layer GT. Current concepts in gynaecomastia. Surgeon. Apr 2009;7(2):114-9. [Medline].
Nydick M, Bustos J, Dale JH Jr, Rawson RW. Gynecomastia in adolescent boys. JAMA. Nov 4 1961;178:449-54. [Medline].
Webster GV. Gynecomastia in the Navy. Mil Surg. 1944;95:375-9.
Williams GM. Gynecomastia. N Engl J Med. Jul 15 1993;329(3):209. [Medline].
Eckman A, Dobs A. Drug-induced gynecomastia. Expert Opin Drug Saf. Nov 2008;7(6):691-702. [Medline].
Morrone N, Morrone Junior N, Braz AG, Maia JA. Gynecomastia: a rare adverse effect of isoniazid. J Bras Pneumol. Nov 2008;34(11):978-81. [Medline].
Parker LN, Gray DR, Lai MK, Levin ER. Treatment of gynecomastia with tamoxifen: a double-blind crossover study. Metabolism. Aug 1986;35(8):705-8. [Medline].
Parker S. A male breast lesion. Surgical-tutor.org.uk [online]. Available at: http://www.surgical-tutor.org.uk/core/neoplasia/gynaecomastia.htm. January 2, 2003;[Full Text].
Pensler JM, Sliverman BL, Sanghavi J, Goolsby C, Brizio-Molteni L and Molteni A. Estrogen and Progesterone receptors in gynecomastia. Plas Reconstr Surg. 2000;106:1011-1013.
Simon BE, Hoffman S, Kahn S. Classification and surgical correction of gynecomastia. Plast Reconstr Surg. Jan 1973;51(1):48-52. [Medline].
Yost, M. Demystifying Gynecomastia: Men with Breasts. Vol 1. ISBN 0-9777199-0-1: Mens Health; 2006:1-122.
Singer-Granick CJ, Granick MS. Gynecomastia what the surgeon needs to know. Eplasty. 2009;9:e6. [Medline].
Teimourian B, Perlman R. Surgery for gynecomastia. Aesthetic Plast Surg. 1983;7(3):155-7. [Medline].
Al Qattan M, Hassanain J. On the neglected entity of unilateral gynecomastia. Ann Plast Surg. 2005;55(3):255-7.
Bembo SA, Carlson HE. Gynecomastia: its features, and when and how to treat it. Cleveland Clin J Med. 1994;71(6):511-7.
Braunstein GD. Gynecomastia. N Engl J Med. Feb 18 1993;328(7):490-5. [Medline].
Burke CW. Gynaecomastia. Practitioner. Aug 1982;226(1370):1403-10. [Medline].
Georgiade GS, Georgiade NG, Riefkohl R, Barwick WJ, eds. Plastic, Maxillofacial and Reconstructive Surgery. 2nd ed. Baltimore, Md: Williams & Wilkins; 1996:877-82.
Goldwyn RM, Cohen MN, eds. The Unfavorable Result in Plastic Surgery: Avoidance and Treatment. 3rd ed. Baltimore, Md: Lippincott Williams & Wilkins; 2001:663-73.
Jayapaul M. Recurrent painful unilateral gynaecomastia-interactions between hyperthyroidism and hypogonadism. Andrologia. 2006;38(1):31-3.
Jurkiewics MJ, Mathes SJ, Krizek TJ, eds. Plastic Surgery: Principles and Practice. Vol 2. St. Louis, Mo: Mosby; 1990:1119-36.
Leibovitch I. Incidence and management of gynecomastia in men treated for prostate. J Urology. 2006;175(5):1962-3.
Letterman G, Schurter M. Breast Gynecomastia. 1976.
Persichetti P, Berloco M, Casadei RM. Gynecomastia. In: Miller SH, ed. Year Book of Plastic, Reconstructive and Aesthetic Surgery. Vol 107. St. Louis, Mo: Mosby Year-Book; 2001:948-54.
Ravel R. Clinical Laboratory Medicine. 4th ed. St. Louis, Mo: Mosby Year-Book; 1994.
Simon BE, Hoffman S. Breast Gynecomastia. 1976.
Wiesman IM, Lehman JA. Gynecomastia: an outcome analysis. Ann Plast Surg. 2004;53(2):97-101.
Wilson JD, Foster DW, Kronenberg HN, Larsen PR. Disorders of breasts in men. In: Wilson JD, Foster DW, eds. Williams Textbook of Endocrinology. 9th ed. Philadelphia, Pa: WB Saunders; 1998:885-93.
Further Reading
Keywords
male breast enlargement, female-like breasts, feminization, male feminization, mastectomy, liposuction-assisted mastectomy, reduction mammaplasty, male breast lesion, male breast abnormality, male breast anomaly, feminized male breast, breast mass, male breast mass, congenital anorchia, Klinefelter syndrome, Klinefelter's syndrome, testicular feminization, hermaphroditism, hermaphrodite, adrenal carcinoma, adrenal cancer, liver disorder, hepatic disorder, liver disease, hepatic disease, malnutrition, testosterone deficiency, gynecomastia, ideopathic gynecomastia, surgical gynecomastia, glandular gynecomastia
Follow-up: Gynecomastia